Squarepoint’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.55M Buy
35,800
+33,300
+1,332% +$2.63M ﹤0.01% 2008
2025
Q4
$205K Sell
2,500
-22,300
-90% -$1.74M ﹤0.01% 3855
2025
Q3
$1.86M Sell
24,800
-43,200
-64% -$3.22M ﹤0.01% 2165
2025
Q2
$5.04M Buy
68,000
+61,300
+915% +$4.27M 0.01% 1460
2025
Q1
$541K Sell
6,700
-43,000
-87% -$3.7M ﹤0.01% 3224
2024
Q4
$3.89M Buy
49,700
+36,300
+271% +$3.09M ﹤0.01% 1839
2024
Q3
$1.26M Buy
13,400
+6,600
+97% +$554K ﹤0.01% 2420
2024
Q2
$530K Buy
6,800
+1,000
+17% +$81.6K ﹤0.01% 3030
2024
Q1
$527K Sell
5,800
-73,100
-93% -$6.08M ﹤0.01% 3003
2023
Q4
$6.1M Buy
78,900
+67,900
+617% +$4.76M 0.01% 1273
2023
Q3
$748K Buy
+11,000
New +$800K ﹤0.01% 2518

Other funds holding GEHC

Squarepoint's GEHC Position: Q1 2026 in Review

Squarepoint reduced its GE HealthCare (GEHC) stake by 0.21% in Q1 2026, selling an estimated $1.97K and leaving 12,115 shares worth $862K. The position accounts for ﹤0.01% of the portfolio, ranked #2909.

Squarepoint first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $31.6M in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Squarepoint held 12,115 shares of GE HealthCare worth $862K as of Q1 2026.
  • Squarepoint sold 25 GE HealthCare shares in Q1 2026, an estimated $1.97K.
  • GE HealthCare made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2909 holding.
  • Squarepoint first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Squarepoint's GE HealthCare position peaked at $31.6M in Q3 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.